{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T04:30:11Z","timestamp":1763699411172,"version":"3.45.0"},"reference-count":184,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regenerative Therapy"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.reth.2025.02.009","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T13:55:48Z","timestamp":1741096548000},"page":"1-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Role of cell-based therapies in digestive disorders: Obstacles and opportunities"],"prefix":"10.1016","volume":"29","author":[{"given":"Guodong","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuehan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shufeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haihang","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hairui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunda","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.reth.2025.02.009_bib1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/bjh.15254","article-title":"Pathogenesis, diagnosis and treatment of anaemia in immune-mediated gastrointestinal disorders","volume":"182","author":"Bergamaschi","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.reth.2025.02.009_bib2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2147\/JIR.S190929","article-title":"Inflammatory bowel diseases: time of diagnosis, environmental factors, clinical course, and management\u2013a follow-up study in a private inflammatory bowel disease center (2003\u20132017)","volume":"12","author":"Cury","year":"2019","journal-title":"J Inflamm Res"},{"issue":"1","key":"10.1016\/j.reth.2025.02.009_bib3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41392-024-01856-7","article-title":"Exploring treatment options in cancer: tumor treatment strategies","volume":"9","author":"Liu","year":"2024","journal-title":"Signal Transduct Targeted Ther"},{"issue":"4","key":"10.1016\/j.reth.2025.02.009_bib4","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3748\/wjg.v30.i4.286","article-title":"Revolutionizing gastric cancer treatment: the potential of immunotherapy","volume":"30","author":"Christodoulidis","year":"2024","journal-title":"World J Gastroenterol"},{"issue":"40","key":"10.1016\/j.reth.2025.02.009_bib5","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.3748\/wjg.v29.i40.5593","article-title":"Advances and key focus areas in gastric cancer immunotherapy: a comprehensive scientometric and clinical trial review (1999-2023)","volume":"29","author":"Li","year":"2023","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.reth.2025.02.009_bib6","article-title":"Bibliometric study of immunotherapy for hepatocellular carcinoma","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.reth.2025.02.009_bib7","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s00432-024-05855-7","article-title":"Liver cancer from the perspective of single-cell sequencing: a review combined with bibliometric analysis","volume":"150","author":"Ji","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"issue":"7","key":"10.1016\/j.reth.2025.02.009_bib8","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00103-011-1300-7","article-title":"A comprehensive assessment of ATMP. Difficulties and approaches","volume":"54","author":"Thanner","year":"2011","journal-title":"Bundesgesundheitsblatt - Gesundheitsforsch - Gesundheitsschutz"},{"issue":"5","key":"10.1016\/j.reth.2025.02.009_bib9","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1053\/jhep.2003.50202","article-title":"Differentiation of embryonic stem cells into hepatocytes: biological functions and therapeutic application","volume":"37","author":"Yamamoto","year":"2003","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.reth.2025.02.009_bib10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/096368979300200109","article-title":"Hepatocyte transplantation in man","volume":"2","author":"Mito","year":"1993","journal-title":"Cell Transplant"},{"issue":"3","key":"10.1016\/j.reth.2025.02.009_bib11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/annrheumdis-2018-214024","article-title":"Tolerising cellular therapies: what is their promise for autoimmune disease?","volume":"78","author":"Mosanya","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.reth.2025.02.009_bib12","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/SGA.0000000000000847","article-title":"Fecal microbiota, live-jslm (RBL; REBYOTA \u00ae ) for prevention of recurrent clostridioides difficile infection: what gastroenterology nurses need to know","volume":"47","author":"Cotto","year":"2024","journal-title":"Gastroenterol Nurs"},{"issue":"6","key":"10.1016\/j.reth.2025.02.009_bib13","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.cell.2023.02.034","article-title":"Fecal microbiota-based treatment for recurrent Clostridioides difficile infection","volume":"186","author":"Walter","year":"2023","journal-title":"Cell."},{"issue":"3","key":"10.1016\/j.reth.2025.02.009_bib14","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.gtc.2014.05.007","article-title":"Pharmacokinetics of biologics and the role of therapeutic monitoring","volume":"43","author":"Lin","year":"2014","journal-title":"Gastroenterol Clin N Am"},{"issue":"6","key":"10.1016\/j.reth.2025.02.009_bib15","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.trsl.2014.01.002","article-title":"Biologic therapies in inflammatory bowel disease","volume":"163","author":"Cohen","year":"2014","journal-title":"Transl Res"},{"issue":"11","key":"10.1016\/j.reth.2025.02.009_bib16","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/81326","article-title":"Purified hematopoietic stem cells can differentiate into hepatocytes in vivo","volume":"6","author":"Lagasse","year":"2000","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.reth.2025.02.009_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/j.gastro.2017.03.022","article-title":"Sphingosine-1-phosphate prevents egress of hematopoietic stem cells from liver to reduce fibrosis","volume":"153","author":"King","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.reth.2025.02.009_bib18","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4197857","article-title":"Current perspectives regarding stem cell-based therapy for liver cirrhosis","volume":"2018","author":"Kwak","year":"2018","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.reth.2025.02.009_bib19","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.3389\/fimmu.2018.02602","article-title":"Autologous hematopoietic stem cell transplantation for autoimmune diseases: from mechanistic insights to biomarkers","volume":"9","author":"Malmegrim","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.reth.2025.02.009_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jaut.2018.06.002","article-title":"Hematopoietic stem cell therapy for autoimmune diseases\u2013Clinical experience and mechanisms","volume":"92","author":"Alexander","year":"2018","journal-title":"J Autoimmun"},{"issue":"27","key":"10.1016\/j.reth.2025.02.009_bib21","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1182\/bloodadvances.2017010041","article-title":"Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases","volume":"1","author":"Snowden","year":"2017","journal-title":"Adv Blood"},{"issue":"4","key":"10.1016\/j.reth.2025.02.009_bib22","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000142333","article-title":"Mesenchymal stem cells\u2013sources and clinical applications","volume":"35","author":"Klingemann","year":"2008","journal-title":"Transfus Med Hemotherapy"},{"issue":"4","key":"10.1016\/j.reth.2025.02.009_bib23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"issue":"5","key":"10.1016\/j.reth.2025.02.009_bib24","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s12015-016-9677-1","article-title":"Therapeutic potential of secreted molecules derived from human amniotic fluid mesenchymal stem\/stroma cells in a mice model of colitis","volume":"12","author":"Legaki","year":"2016","journal-title":"Stem Cell Rev Rep"},{"issue":"4","key":"10.1016\/j.reth.2025.02.009_bib25","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/leu.2014.41","article-title":"MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease","volume":"28","author":"Kordelas","year":"2014","journal-title":"Leukemia"},{"issue":"5\u20138","key":"10.1016\/j.reth.2025.02.009_bib26","article-title":"Mesenchymal stem cell therapy for the treatment of inflammatory diseases: challenges, opportunities, and future perspectives","volume":"98","author":"Regmi","year":"2019","journal-title":"Eur J Cell Biol"},{"issue":"12","key":"10.1016\/j.reth.2025.02.009_bib27","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1182\/blood-2003-11-3909","article-title":"Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2, 3-dioxygenase\u2013mediated tryptophan degradation","volume":"103","author":"Meisel","year":"2004","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.reth.2025.02.009_bib28","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1365-3083.2007.01905.x","article-title":"Mesenchymal stem cells stimulate antibody secretion in human B cells","volume":"65","author":"Rasmusson","year":"2007","journal-title":"Scand J Immunol"},{"issue":"1","key":"10.1016\/j.reth.2025.02.009_bib29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11373-004-8183-7","article-title":"T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression","volume":"12","author":"Klyushnenkova","year":"2005","journal-title":"J Biomed Sci"},{"issue":"8","key":"10.1016\/j.reth.2025.02.009_bib30","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/gutjnl-2012-302152","article-title":"Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from experimental colitis and sepsis","volume":"62","author":"Anderson","year":"2013","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.reth.2025.02.009_bib31","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1182\/blood-2004-07-2921","article-title":"Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness","volume":"105","author":"Beyth","year":"2005","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.reth.2025.02.009_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047559","article-title":"Safe ty of cell therapy with mesenchymal stromal cells (safecell): a systematic review and meta-analysis of clinical trials","volume":"7","author":"Lalu","year":"2012","journal-title":"PLoS One"},{"issue":"5609","key":"10.1016\/j.reth.2025.02.009_bib33","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.reth.2025.02.009_bib34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/ni.2554","article-title":"Regulatory T cells: recommendations to simplify the nomenclature","volume":"14","author":"Abbas","year":"2013","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.reth.2025.02.009_bib35","first-page":"116","article-title":"Advances in distinguishing natural from induced Foxp3+ regulatory T cells","volume":"6","author":"Lin","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.reth.2025.02.009_bib36","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3389\/fimmu.2016.00345","article-title":"Improving adoptive T cell therapy: the particular role of T cell costimulation, cytokines, and post-transfer vaccination","volume":"7","author":"Redeker","year":"2016","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.reth.2025.02.009_bib37","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2337\/diabetes.54.2.306","article-title":"Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes","volume":"54","author":"Jaeckel","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.reth.2025.02.009_bib38","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.molimm.2017.11.008","article-title":"BMSCs-derived miR-223-containing exosomes contribute to liver protection in experimental autoimmune hepatitis","volume":"93","author":"Chen","year":"2018","journal-title":"Mol Immunol"},{"issue":"1","key":"10.1016\/j.reth.2025.02.009_bib39","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/hep.26023","article-title":"Adoptive transfer of ex vivo expanded regulatory T cells in an autoimmune hepatitis murine model restores peripheral tolerance","volume":"57","author":"Lapierre","year":"2013","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.reth.2025.02.009_bib40","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/hep.24039","article-title":"Autoantigen-specific regulatory T cells, a potential tool for immune-tolerance reconstitution in type-2 autoimmune hepatitis","volume":"53","author":"Longhi","year":"2011","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.reth.2025.02.009_bib41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10238-010-0105-6","article-title":"Effect of allogeneic bone marrow\u2013derived mesenchymal stem cells transplantation in a polyI: C-induced primary biliary cirrhosis mouse model","volume":"11","author":"Wang","year":"2011","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.reth.2025.02.009_bib42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/jgh.12029","article-title":"A pilot study of umbilical cord-derived mesenchymal stem cell transfusion in patients with primary biliary cirrhosis","volume":"28","author":"Wang","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"issue":"20","key":"10.1016\/j.reth.2025.02.009_bib43","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1089\/scd.2013.0500","article-title":"Allogeneic bone marrow mesenchymal stem cell transplantation in patients with UDCA-resistant primary biliary cirrhosis","volume":"23","author":"Wang","year":"2014","journal-title":"Stem Cell Dev"},{"issue":"4","key":"10.1016\/j.reth.2025.02.009_bib44","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jhep.2016.12.001","article-title":"Dysfunction of hepatic regulatory T cells in experimental sclerosing cholangitis is related to IL-12 signaling","volume":"66","author":"Schwinge","year":"2017","journal-title":"J Hepatol"},{"issue":"Suppl1","key":"10.1016\/j.reth.2025.02.009_bib45","article-title":"Mesenchymal stem cells as potential therapeutic approaches in celiac disease","volume":"9","author":"Moheb-Alian","year":"2016","journal-title":"Gastroenterol Hepatol from Bed to Bench"},{"issue":"8","key":"10.1016\/j.reth.2025.02.009_bib46","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s10875-013-9943-9","article-title":"Celiac disease resolution after allogeneic bone marrow transplantation is associated with absence of gliadin-specific memory response by donor-derived intestinal T-cells","volume":"33","author":"Ben-Horin","year":"2013","journal-title":"J Clin Immunol"},{"issue":"4","key":"10.1016\/j.reth.2025.02.009_bib47","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/MPG.0b013e318276a6a7","article-title":"Allogeneic hematopoietic stem cell transplantation may restore gluten tolerance in patients with celiac disease","volume":"56","author":"Ciccocioppo","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"7","key":"10.1016\/j.reth.2025.02.009_bib48","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.dld.2007.03.009","article-title":"Disappointing outcome of autologous stem cell transplantation for enteropathy-associated T-cell lymphoma","volume":"39","author":"Al-Toma","year":"2007","journal-title":"Dig Liver Dis: Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"issue":"12","key":"10.1016\/j.reth.2025.02.009_bib49","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1182\/blood-2003-11-3909","article-title":"Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation","volume":"103","author":"Meisel","year":"2004","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.reth.2025.02.009_bib50","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1749-0774.2006.00010.x","article-title":"Regeneration of the intestinal epithelia: regulation of bone marrow-derived epithelial cell differentiation towards secretory lineage cells","volume":"19","author":"Okamoto","year":"2006","journal-title":"Hum Cell"},{"issue":"2","key":"10.1016\/j.reth.2025.02.009_bib51","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/jcp.21172","article-title":"Liver regeneration","volume":"213","author":"Michalopoulos","year":"2007","journal-title":"J Cell Physiol"},{"issue":"1","key":"10.1016\/j.reth.2025.02.009_bib52","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.dld.2007.08.012","article-title":"Experimental hepatology applied to stem cells","volume":"40","author":"Burra","year":"2008","journal-title":"Dig Liver Dis: Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"issue":"5628","key":"10.1016\/j.reth.2025.02.009_bib53","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/269518a0","article-title":"Extreme sensitivity of some intestinal crypt cells to X and gamma irradiation","volume":"269","author":"Potten","year":"1977","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.reth.2025.02.009_bib54","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1053\/j.gastro.2008.01.079","article-title":"Current view: intestinal stem cells and signaling","volume":"134","author":"Scoville","year":"2008","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.reth.2025.02.009_bib55","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/aja.1001410403","article-title":"Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. I. Columnar cell","volume":"141","author":"Cheng","year":"1974","journal-title":"Am J Anat"},{"issue":"7165","key":"10.1016\/j.reth.2025.02.009_bib56","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nature06196","article-title":"Identification of stem cells in small intestine and colon by marker gene Lgr5","volume":"449","author":"Barker","year":"2007","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.reth.2025.02.009_bib57","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/emmm.200900034","article-title":"Searching for adult stem cells in the intestine","volume":"1","author":"Clevers","year":"2009","journal-title":"EMBO Mol Med"},{"issue":"7330","key":"10.1016\/j.reth.2025.02.009_bib58","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature09637","article-title":"Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts","volume":"469","author":"Sato","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.reth.2025.02.009_bib59","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.cell.2010.09.016","article-title":"Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells","volume":"143","author":"Snippert","year":"2010","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.reth.2025.02.009_bib60","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/path.1155","article-title":"Gastrointestinal stem cells","volume":"197","author":"Brittan","year":"2002","journal-title":"J Pathol"},{"issue":"6","key":"10.1016\/j.reth.2025.02.009_bib61","doi-asserted-by":"crossref","first-page":"G1307","DOI":"10.1152\/ajpgi.2000.279.6.G1307","article-title":"IGF-I and procollagen alpha 1(I) are coexpressed in a subset of mesenchymal cells in active Crohn's disease","volume":"279","author":"Pucilowska","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"12","key":"10.1016\/j.reth.2025.02.009_bib62","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00535-005-1727-4","article-title":"Colonic subepithelial myofibroblasts in mucosal inflammation and repair: contribution of bone marrow-derived stem cells to the gut regenerative response","volume":"40","author":"Andoh","year":"2005","journal-title":"J Gastroenterol"},{"issue":"3","key":"10.1016\/j.reth.2025.02.009_bib63","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/hep.21557","article-title":"Identification of hepatocytic and bile ductular cell lineages and candidate stem cells in bipolar ductular reactions in cirrhotic human liver","volume":"45","author":"Zhou","year":"2007","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.reth.2025.02.009_bib64","doi-asserted-by":"crossref","first-page":"G189","DOI":"10.1152\/ajpgi.00041.2005","article-title":"Gastrointestinal stem cells. III. Emergent themes of liver stem cell biology: niche, quiescence, self-renewal, and plasticity","volume":"290","author":"Theise","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"6","key":"10.1016\/j.reth.2025.02.009_bib65","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/hep.21569","article-title":"Remarkable heterogeneity displayed by oval cells in rat and mouse models of stem cell-mediated liver regeneration","volume":"45","author":"Jelnes","year":"2007","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.reth.2025.02.009_bib66","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/hep.22218","article-title":"The hepatic stem cell niche: identification by label-retaining cell assay","volume":"47","author":"Kuwahara","year":"2008","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.reth.2025.02.009_bib67","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/hep.22333","article-title":"Location is everything: the liver stem cell niche","volume":"47","author":"Petersen","year":"2008","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.reth.2025.02.009_bib68","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2174\/157016309789869083","article-title":"Crohn's targeted therapy: myth or real goal?","volume":"6","author":"Schmidt","year":"2009","journal-title":"Curr Drug Discov Technol"},{"issue":"3","key":"10.1016\/j.reth.2025.02.009_bib69","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1053\/j.gastro.2004.11.051","article-title":"Autologous hematopoietic stem cell transplantation in patients with refractory Crohn's disease","volume":"128","author":"Oyama","year":"2005","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.reth.2025.02.009_bib70","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/gut.2007.128694","article-title":"Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease","volume":"57","author":"Cassinotti","year":"2008","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.reth.2025.02.009_bib71","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1182\/blood-2006-08-042820","article-title":"Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells","volume":"109","author":"Al-toma","year":"2007","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.reth.2025.02.009_bib72","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1080\/1042819031000123456","article-title":"High-dose therapy supported by autologous stem cell transplantation in patients with enteropathy-associated T-cell lymphoma","volume":"44","author":"Jantunen","year":"2003","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.reth.2025.02.009_bib73","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2141.2006.06371.x","article-title":"Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T cell lymphoma","volume":"136","author":"Bishton","year":"2007","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.reth.2025.02.009_bib74","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1182\/blood-2007-02-069716","article-title":"Immunomodulatory properties of mesenchymal stromal cells","volume":"110","author":"Nauta","year":"2007","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.reth.2025.02.009_bib75","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1053\/j.gastro.2008.11.041","article-title":"Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses","volume":"136","author":"Gonz\u00e1lez","year":"2009","journal-title":"Gastroenterology"},{"issue":"Pt 9","key":"10.1016\/j.reth.2025.02.009_bib76","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1099\/0022-1317-72-9-2257","article-title":"Actin-independent maturation of rabies virus in neuronal cultures","volume":"72","author":"Lockhart","year":"1991","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.reth.2025.02.009_bib77","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1124\/jpet.108.137083","article-title":"Topical implantation of mesenchymal stem cells has beneficial effects on healing of experimental colitis in rats","volume":"326","author":"Hayashi","year":"2008","journal-title":"J Pharmacol Exp Therapeut"},{"issue":"5","key":"10.1016\/j.reth.2025.02.009_bib78","first-page":"473","article-title":"OTI-010 osiris therapeutics\/JCR pharmaceuticals","volume":"7","author":"Taupin","year":"2006","journal-title":"Curr Opin Invest Drugs"},{"issue":"9624","key":"10.1016\/j.reth.2025.02.009_bib79","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet (London, England)"},{"issue":"5","key":"10.1016\/j.reth.2025.02.009_bib80","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/hep.20703","article-title":"AASLD position paper: the management of acute liver failure","volume":"41","author":"Polson","year":"2005","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.reth.2025.02.009_bib81","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000047017","article-title":"Acute-on-chronic liver failure: pathophysiological basis of therapeutic options","volume":"20","author":"Jalan","year":"2002","journal-title":"Blood Purif"},{"issue":"4","key":"10.1016\/j.reth.2025.02.009_bib82","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1055\/s-2007-1007254","article-title":"Liver transplantation in Europe for patients with acute liver failure","volume":"16","author":"Bismuth","year":"1996","journal-title":"Semin Liver Dis"},{"issue":"1","key":"10.1016\/j.reth.2025.02.009_bib83","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0168-8278(99)80022-1","article-title":"Hepatocyte transplantation: emerging insights into mechanisms of liver repopulation and their relevance to potential therapies","volume":"30","author":"Gupta","year":"1999","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.reth.2025.02.009_bib84","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/jbm.a.30306","article-title":"The viability and function of primary rat hepatocytes cultured on polymeric membranes developed for hybrid artificial liver devices","volume":"73","author":"Grant","year":"2005","journal-title":"J Biomed Mater Res"},{"issue":"5","key":"10.1016\/j.reth.2025.02.009_bib85","first-page":"837","article-title":"Metabolic activity of rat hepatocytes cultured on homologous acellular matrix and transplanted into Gunn rats","volume":"18","author":"Tomat","year":"2006","journal-title":"Int J Mol Med"},{"issue":"4","key":"10.1016\/j.reth.2025.02.009_bib86","first-page":"511","article-title":"Acellular liver matrix improves the survival and functions of isolated rat hepatocytes cultured in vitro","volume":"14","author":"Burra","year":"2004","journal-title":"Int J Mol Med"},{"issue":"3","key":"10.1016\/j.reth.2025.02.009_bib87","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/sj.clpt.6100301","article-title":"Stem cells: a revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies","volume":"82","author":"Mimeault","year":"2007","journal-title":"Clin Pharmacol Therapeut"},{"issue":"7","key":"10.1016\/j.reth.2025.02.009_bib88","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1590-8658(03)00226-3","article-title":"Stem cells: new tools in gastroenterology and hepatology","volume":"35","author":"Piscaglia","year":"2003","journal-title":"Dig Liver Dis: Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"issue":"10","key":"10.1016\/j.reth.2025.02.009_bib89","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1634\/stemcells.2005-0542","article-title":"Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy","volume":"24","author":"Terai","year":"2006","journal-title":"Stem Cell"},{"issue":"1","key":"10.1016\/j.reth.2025.02.009_bib90","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12029-009-9092-9","article-title":"Stem cell therapy improves the outcome of liver resection in cirrhotics","volume":"41","author":"Ismail","year":"2010","journal-title":"J Gastrointest Cancer"},{"issue":"1","key":"10.1016\/j.reth.2025.02.009_bib91","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jhep.2006.02.018","article-title":"Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease","volume":"45","author":"Gaia","year":"2006","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.reth.2025.02.009_bib92","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.exphem.2006.06.012","article-title":"Lasting amelioration in the clinical course of decompensated alcoholic cirrhosis with boost infusions of mobilized peripheral blood stem cells","volume":"34","author":"Yannaki","year":"2006","journal-title":"Exp Hematol"},{"issue":"9","key":"10.1016\/j.reth.2025.02.009_bib93","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.dld.2006.06.037","article-title":"Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis","volume":"39","author":"Gasbarrini","year":"2007","journal-title":"Dig Liver Dis"},{"issue":"7","key":"10.1016\/j.reth.2025.02.009_bib94","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1634\/stemcells.2005-0629","article-title":"Characterization and clinical application of human CD34+ stem\/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor","volume":"24","author":"Gordon","year":"2006","journal-title":"Stem Cell"},{"key":"10.1016\/j.reth.2025.02.009_bib95","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2184.2008.00491.x","article-title":"Long-term clinical results of autologous infusion of mobilized adult bone marrow derived CD34+ cells in patients with chronic liver disease","volume":"41","author":"Levi\u010dar","year":"2008","journal-title":"Cell Prolif"},{"issue":"8","key":"10.1016\/j.reth.2025.02.009_bib96","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1111\/j.1572-0241.2008.01993.x","article-title":"Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis","volume":"103","author":"Pai","year":"2008","journal-title":"Off J Am College Gastroenterol ACG"},{"issue":"4","key":"10.1016\/j.reth.2025.02.009_bib97","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/14653240802129901","article-title":"Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulocyte\u2013colony-stimulating factor mobilization therapy","volume":"10","author":"Han","year":"2008","journal-title":"Cytotherapy"},{"issue":"12","key":"10.1016\/j.reth.2025.02.009_bib98","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.dld.2007.08.006","article-title":"Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure","volume":"39","author":"Di Campli","year":"2007","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10.1016\/j.reth.2025.02.009_bib99","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/hep.22317","article-title":"Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial","volume":"48","author":"Spahr","year":"2008","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.reth.2025.02.009_bib100","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/lt.21965","article-title":"Bone marrow-derived stem cells in liver repair: 10 years down the line","volume":"16","author":"Gilchrist","year":"2010","journal-title":"Liver Transplant"},{"issue":"5","key":"10.1016\/j.reth.2025.02.009_bib101","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/gut.2006.098442","article-title":"Bone marrow stem cells and liver disease","volume":"56","author":"Kallis","year":"2007","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.reth.2025.02.009_bib102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-8722-6-47","article-title":"Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges","volume":"6","author":"Han","year":"2013","journal-title":"J Hematol Oncol"},{"issue":"9","key":"10.1016\/j.reth.2025.02.009_bib103","doi-asserted-by":"crossref","first-page":"899","DOI":"10.2217\/imt.12.91","article-title":"Safety and stability of retrovirally transduced chimeric antigen receptor T cells","volume":"4","author":"Colovos","year":"2012","journal-title":"Immunotherapy"},{"issue":"4","key":"10.1016\/j.reth.2025.02.009_bib104","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1158\/2326-6066.CIR-14-0186","article-title":"Identification of chimeric antigen receptors that mediate constitutive or inducible proliferation of T CellsConstitutive CAR T-cell proliferation","volume":"3","author":"Frigault","year":"2015","journal-title":"Cancer Immunol Res"},{"issue":"10","key":"10.1016\/j.reth.2025.02.009_bib105","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1089\/hum.2012.202","article-title":"Modification of hematopoietic stem\/progenitor cells with CD19-specific chimeric antigen receptors as a novel approach for cancer immunotherapy","volume":"24","author":"De Oliveira","year":"2013","journal-title":"Hum Gene Ther"},{"issue":"2","key":"10.1016\/j.reth.2025.02.009_bib106","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/gt.2014.104","article-title":"The Tol2 transposon system mediates the genetic engineering of T-cells with CD19-specific chimeric antigen receptors for B-cell malignancies","volume":"22","author":"Tsukahara","year":"2015","journal-title":"Gene Ther"},{"issue":"8","key":"10.1016\/j.reth.2025.02.009_bib107","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1038\/s41591-024-03037-z","article-title":"Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results","volume":"30","author":"Qi","year":"2024","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.reth.2025.02.009_bib108","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00408-023-00648-0","article-title":"Targeting CDH17 with chimeric antigen receptor-redirected T cells in small cell lung cancer","volume":"201","author":"Tian","year":"2023","journal-title":"Lung"},{"issue":"4","key":"10.1016\/j.reth.2025.02.009_bib109","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/mt.2010.24","article-title":"Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2","volume":"18","author":"Morgan","year":"2010","journal-title":"Mol Ther"},{"issue":"5","key":"10.1016\/j.reth.2025.02.009_bib110","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/mt.2014.41","article-title":"Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells","volume":"22","author":"Blat","year":"2014","journal-title":"Mol Ther"},{"issue":"5","key":"10.1016\/j.reth.2025.02.009_bib111","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/cgt.2016.14","article-title":"Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic delivery","volume":"23","author":"Katz","year":"2016","journal-title":"Cancer Gene Ther"},{"issue":"7","key":"10.1016\/j.reth.2025.02.009_bib112","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00262-015-1692-6","article-title":"Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T","volume":"64","author":"Burga","year":"2015","journal-title":"Cancer Immunol Immunother"},{"issue":"14","key":"10.1016\/j.reth.2025.02.009_bib113","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1158\/1078-0432.CCR-14-1421","article-title":"Phase I hepatic immunotherapy for metastases study of intra-arterial chimeric antigen receptor\u2013modified T-cell therapy for CEA+ liver MetastasesHepatic artery CAR-T infusions","volume":"21","author":"Katz","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.reth.2025.02.009_bib114","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1053\/j.gastro.2013.04.047","article-title":"T cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice","volume":"145","author":"Krebs","year":"2013","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.reth.2025.02.009_bib115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/172460080101600204","article-title":"Clinical evaluation of lentil lectin-reactive alpha-fetoprotein-L3 in histology-proven hepatocellular carcinoma","volume":"16","author":"Khien","year":"2001","journal-title":"Int J Biol Markers"},{"issue":"8","key":"10.1016\/j.reth.2025.02.009_bib116","first-page":"1610","article-title":"Sperm protein 17, MAGE-C1 and NY-ESO-1 in hepatocellular carcinoma: expression frequency and their correlation with clinical parameters","volume":"6","author":"Xia","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"10.1016\/j.reth.2025.02.009_bib117","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/s12967-023-04292-3","article-title":"Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments","volume":"21","author":"Dagar","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.reth.2025.02.009_bib118","article-title":"The current landscape of CAR T-cell therapy for solid tumors: mechanisms, research progress, challenges, and counterstrategies","volume":"14","author":"Daei","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.reth.2025.02.009_bib119","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1431211","article-title":"Regulatory T cells and immune escape in HCC: understanding the tumor microenvironment and advancing CAR-T cell therapy","volume":"15","author":"Du","year":"2024","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.reth.2025.02.009_bib120","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001875","article-title":"Shed antigen-induced blocking effect on CAR-T cells targeting Glypican-3 in Hepatocellular Carcinoma","volume":"9","author":"Sun","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.reth.2025.02.009_bib121","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.876339","article-title":"Impact of manufacturing procedures on CAR T cell functionality","volume":"13","author":"Watanabe","year":"2022","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.reth.2025.02.009_bib122","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jtct.2023.04.001","article-title":"Anakinra for refractory cytokine release syndrome or immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor T cell therapy","volume":"29","author":"Gazeau","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"19","key":"10.1016\/j.reth.2025.02.009_bib123","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12196124","article-title":"Exploring CAR-T cell therapy side effects: mechanisms and management strategies","volume":"12","author":"Zhang","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.reth.2025.02.009_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1399544","article-title":"Challenges and innovations in CAR-T cell therapy: a comprehensive analysis","volume":"14","author":"Luo","year":"2024","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.reth.2025.02.009_bib125","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","article-title":"CAR-T cell therapy: current limitations and potential strategies","volume":"11","author":"Sterner","year":"2021","journal-title":"Blood Cancer J"},{"issue":"19","key":"10.1016\/j.reth.2025.02.009_bib126","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.3748\/wjg.v22.i19.4619","article-title":"HER2 testing in gastric cancer: an update","volume":"22","author":"Abrahao-Machado","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"11","key":"10.1016\/j.reth.2025.02.009_bib127","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.5858\/arpa.2013-0604-OA","article-title":"HER2\/neu testing in gastric cancer by immunohistochemistry: assessment of interlaboratory variation","volume":"138","author":"Sheffield","year":"2014","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1016\/j.reth.2025.02.009_bib128","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.cll.2013.08.006","article-title":"Molecular diagnostics in esophageal and gastric neoplasms","volume":"33","author":"Zulfiqar","year":"2013","journal-title":"Clin Lab Med"},{"issue":"3","key":"10.1016\/j.reth.2025.02.009_bib129","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2217\/imt.14.120","article-title":"ErbB-targeted CAR T-cell immunotherapy of cancer","volume":"7","author":"Whilding","year":"2015","journal-title":"Immunotherapy"},{"issue":"1","key":"10.1016\/j.reth.2025.02.009_bib130","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju364","article-title":"Selective bispecific T cell recruiting antibody and antitumor activity of adoptive T cell transfer","volume":"107","author":"Kobold","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"10.1016\/j.reth.2025.02.009_bib131","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1158\/0008-5472.CAN-09-0564","article-title":"CAR mechanics: driving T cells into the MUC of cancer","volume":"69","author":"Maher","year":"2009","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.reth.2025.02.009_bib132","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s10875-012-9689-9","article-title":"Dual targeting of ErbB2 and MUC1 in breast cancer using chimeric antigen receptors engineered to provide complementary signaling","volume":"32","author":"Wilkie","year":"2012","journal-title":"J Clin Immunol"},{"issue":"8","key":"10.1016\/j.reth.2025.02.009_bib133","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1038\/bjc.2013.536","article-title":"Members of the EpCAM signalling pathway are expressed in gastric cancer tissue and are correlated with patient prognosis","volume":"109","author":"Warneke","year":"2013","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.reth.2025.02.009_bib134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12865-014-0064-x","article-title":"Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM","volume":"16","author":"Deng","year":"2015","journal-title":"BMC Immunol"},{"issue":"8","key":"10.1016\/j.reth.2025.02.009_bib135","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/gt.2015.29","article-title":"B7H6-specific chimeric antigen receptors lead to tumor elimination and host antitumor immunity","volume":"22","author":"Wu","year":"2015","journal-title":"Gene Ther"},{"issue":"4B","key":"10.1016\/j.reth.2025.02.009_bib136","first-page":"2225","article-title":"Arp 2\/3 overexpression contributed to pathogenesis, growth and invasion of gastric carcinoma","volume":"28","author":"Zheng","year":"2008","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.reth.2025.02.009_bib137","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/path.2717","article-title":"Search for transmembrane protein in gastric cancer by the Escherichia coli ampicillin secretion trap: expression of DSC2 in gastric cancer with intestinal phenotype","volume":"221","author":"Anami","year":"2010","journal-title":"J Pathol: J Pathol Soc Great Brit Ireland"},{"issue":"24","key":"10.1016\/j.reth.2025.02.009_bib138","doi-asserted-by":"crossref","first-page":"8112","DOI":"10.1158\/1078-0432.CCR-07-4910","article-title":"Second-generation anti\u2013carcinoembryonic antigen designer T cells resist activation-induced cell death, proliferate on tumor contact, secrete cytokines, and exhibit superior antitumor activity in vivo: a preclinical evaluation","volume":"14","author":"Emtage","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.reth.2025.02.009_bib139","doi-asserted-by":"crossref","first-page":"171","DOI":"10.18632\/oncotarget.2767","article-title":"Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57","volume":"6","author":"Zhu","year":"2015","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.reth.2025.02.009_bib140","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s11427-016-5023-8","article-title":"Chimeric antigen receptor-modified T cells for the immunotherapy of patients with EGFR-expressing advanced relapsed\/refractory non-small cell lung cancer","volume":"59","author":"Feng","year":"2016","journal-title":"Sci China Life Sci"},{"issue":"5","key":"10.1016\/j.reth.2025.02.009_bib141","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1586\/14737159.5.5.701","article-title":"Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer","volume":"5","author":"Frick","year":"2005","journal-title":"Expert Rev Mol Diagn"},{"issue":"3","key":"10.1016\/j.reth.2025.02.009_bib142","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2217\/bmm.12.24","article-title":"GUCY2C molecular staging personalizes colorectal cancer patient management","volume":"6","author":"Gong","year":"2012","journal-title":"Biomarkers Med"},{"issue":"2","key":"10.1016\/j.reth.2025.02.009_bib143","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12026-011-8253-7","article-title":"GUCY2C-targeted cancer immunotherapy: past, present and future","volume":"51","author":"Snook","year":"2011","journal-title":"Immunol Res"},{"issue":"8","key":"10.1016\/j.reth.2025.02.009_bib144","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.5858\/arpa.2013-0452-OA","article-title":"Cadherin-17 and SATB2 are sensitive and specific immunomarkers for medullary carcinoma of the large intestine","volume":"138","author":"Lin","year":"2014","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1016\/j.reth.2025.02.009_bib145","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.humpath.2012.04.017","article-title":"Immunohistochemistry of colorectal carcinoma: current practice and evolving applications","volume":"44","author":"Taliano","year":"2013","journal-title":"Hum Pathol"},{"issue":"11","key":"10.1016\/j.reth.2025.02.009_bib146","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/modpathol.2008.107","article-title":"Cadherin-17 is a useful diagnostic marker for adenocarcinomas of the digestive system","volume":"21","author":"Su","year":"2008","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.reth.2025.02.009_bib147","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1084\/jem.20031435","article-title":"Mesothelin-specific CD8+ T cell responses provide evidence of in vivo cross-priming by antigen-presenting cells in vaccinated pancreatic cancer patients","volume":"200","author":"Thomas","year":"2004","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.reth.2025.02.009_bib148","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/mt.2011.256","article-title":"Redirected antitumor activity of primary human lymphocytes transduced with a fully human anti-mesothelin chimeric receptor","volume":"20","author":"Lanitis","year":"2012","journal-title":"Mol Ther"},{"issue":"2","key":"10.1016\/j.reth.2025.02.009_bib149","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1158\/2326-6066.CIR-13-0170","article-title":"Mesothelin-Specific chimeric antigen receptor mRNA-engineered T cells induce antitumor activity in solid MalignanciesCase report: RNA CAR T cells","volume":"2","author":"Beatty","year":"2014","journal-title":"Cancer Immunol Res"},{"issue":"9","key":"10.1016\/j.reth.2025.02.009_bib150","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/mt.2016.146","article-title":"Feasibility and safety of RNA-transfected CD20-specific chimeric antigen receptor T cells in dogs with spontaneous B cell lymphoma","volume":"24","author":"Panjwani","year":"2016","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.reth.2025.02.009_bib151","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1158\/2326-6066.CIR-13-0006","article-title":"T cells expressing chimeric antigen receptors can cause anaphylaxis in HumansCAR-T\u2013mediated anaphylaxis","volume":"1","author":"Maus","year":"2013","journal-title":"Cancer Immunol Res"},{"issue":"9","key":"10.1016\/j.reth.2025.02.009_bib152","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1477-2574.2011.00344.x","article-title":"Engineered T cells for pancreatic cancer treatment","volume":"13","author":"Katari","year":"2011","journal-title":"Hpb"},{"issue":"12","key":"10.1016\/j.reth.2025.02.009_bib153","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1089\/hum.2013.209","article-title":"A novel chimeric antigen receptor against prostate stem cell antigen mediates tumor destruction in a humanized mouse model of pancreatic cancer","volume":"25","author":"Abate-Daga","year":"2014","journal-title":"Hum Gene Ther"},{"issue":"4","key":"10.1016\/j.reth.2025.02.009_bib154","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1053\/j.gastro.2012.06.037","article-title":"T cells that target carcinoembryonic antigen eradicate orthotopic pancreatic carcinomas without inducing autoimmune colitis in mice","volume":"143","author":"Chmielewski","year":"2012","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.reth.2025.02.009_bib155","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1053\/j.gastro.2012.07.017","article-title":"Redirected T cells that target pancreatic adenocarcinoma antigens eliminate tumors and metastases in mice","volume":"143","author":"Maliar","year":"2012","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.reth.2025.02.009_bib156","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.immuni.2016.05.014","article-title":"Engineered CAR T cells targeting the cancer-associated Tn-glycoform of the membrane mucin MUC1 control adenocarcinoma","volume":"44","author":"Posey","year":"2016","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.reth.2025.02.009_bib157","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nm.3833","article-title":"Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes","volume":"21","author":"Caruana","year":"2015","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.reth.2025.02.009_bib158","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-015-0460-x","article-title":"A phase I clinical trial of adoptive T cell therapy using IL-12 secreting MUC-16ecto directed chimeric antigen receptors for recurrent ovarian cancer","volume":"13","author":"Koneru","year":"2015","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.reth.2025.02.009_bib159","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4161\/onci.1.1.18344","article-title":"Immunotherapy of hepatocellular carcinoma: unique challenges and clinical opportunities","volume":"1","author":"Pardee","year":"2012","journal-title":"OncoImmunology"},{"issue":"24","key":"10.1016\/j.reth.2025.02.009_bib160","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.1158\/1078-0432.CCR-14-1170","article-title":"Development of T Cells redirected to glypican-3 for the treatment of hepatocellular CarcinomaGPC3-targeted CAR T cells for HCC treatment","volume":"20","author":"Gao","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.reth.2025.02.009_bib161","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1054\/bjoc.2000.1580","article-title":"Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma","volume":"84","author":"Ito","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.reth.2025.02.009_bib162","article-title":"Biomarkers for hepatocellular carcinoma","volume":"2012","author":"Behne","year":"2012","journal-title":"Bangladesh Liver J"},{"issue":"6","key":"10.1016\/j.reth.2025.02.009_bib163","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/bmt.2014.55","article-title":"Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation","volume":"49","author":"Passweg","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.reth.2025.02.009_bib164","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2796.2012.02547.x","article-title":"Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adult patients with acute myeloid leukaemia, an Acute Leukaemia Working Party analysis in 2262 patients","volume":"272","author":"Ringden","year":"2012","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.reth.2025.02.009_bib165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-9255-2-8","article-title":"Mesenchymal stem cells avoid allogeneic rejection","volume":"2","author":"Ryan","year":"2005","journal-title":"J Inflamm"},{"issue":"22","key":"10.1016\/j.reth.2025.02.009_bib166","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","article-title":"Comparison of allogeneic vs autologous bone marrow\u2013derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial","volume":"308","author":"Hare","year":"2012","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.reth.2025.02.009_bib167","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/stem.1111","article-title":"Are therapeutic human mesenchymal stromal cells compatible with human blood?","volume":"30","author":"Moll","year":"2012","journal-title":"Stem Cell"},{"issue":"10","key":"10.1016\/j.reth.2025.02.009_bib168","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.2337\/diabetes.48.10.1907","article-title":"Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation?","volume":"48","author":"Bennet","year":"1999","journal-title":"Diabetes"},{"issue":"416","key":"10.1016\/j.reth.2025.02.009_bib169","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam7828","article-title":"Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation","volume":"9","author":"Galleu","year":"2017","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.reth.2025.02.009_bib170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-015-0245-4","article-title":"Autophagy promotes apoptosis of mesenchymal stem cells under inflammatory microenvironment","volume":"6","author":"Dang","year":"2015","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"10.1016\/j.reth.2025.02.009_bib171","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/stem.2779","article-title":"Immunomodulation by therapeutic mesenchymal stromal cells (MSC) is triggered through phagocytosis of MSC by monocytic cells","volume":"36","author":"de Witte","year":"2018","journal-title":"Stem Cell"},{"issue":"6","key":"10.1016\/j.reth.2025.02.009_bib172","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2018.01.030","article-title":"Mesenchymal stromal cell therapy for liver diseases","volume":"68","author":"Alfaifi","year":"2018","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.reth.2025.02.009_bib173","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3324\/haematol.2012.074088","article-title":"Differential effects of rapamycin and retinoic acid on expansion, stability and suppressive qualities of human CD4+ CD25+ FOXP3+ T regulatory cell subpopulations","volume":"98","author":"Scott\u00e0","year":"2013","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.reth.2025.02.009_bib174","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-9-29","article-title":"Risk factors in the development of stem cell therapy","volume":"9","author":"Herberts","year":"2011","journal-title":"J Transl Med"},{"issue":"2","key":"10.1016\/j.reth.2025.02.009_bib175","doi-asserted-by":"crossref","first-page":"382","DOI":"10.5966\/sctm.2016-0201","article-title":"Preventing pluripotent cell teratoma in regenerative medicine applied to hematology disorders","volume":"6","author":"Bedel","year":"2017","journal-title":"Stem Cells Transl Med"},{"issue":"6","key":"10.1016\/j.reth.2025.02.009_bib176","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.stem.2011.05.012","article-title":"Assessing the safety of stem cell therapeutics","volume":"8","author":"Goldring","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.reth.2025.02.009_bib177","article-title":"Reducing risks and delays in the translation of cell and gene therapy innovations into regulated products","volume":"2019","author":"Tsokas","year":"2019","journal-title":"NAM Perspect"},{"issue":"3","key":"10.1016\/j.reth.2025.02.009_bib178","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.stemcr.2017.07.017","article-title":"Neural crest cell implantation restores enteric nervous system function and alters the gastrointestinal transcriptome in human tissue-engineered small intestine","volume":"9","author":"Schlieve","year":"2017","journal-title":"Stem Cell Rep"},{"issue":"6","key":"10.1016\/j.reth.2025.02.009_bib179","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/sctm.20-0469","article-title":"Premigratory neural crest stem cells generate enteric neurons populating the mouse colon and regulating peristalsis in tissue-engineered intestine","volume":"10","author":"Yuan","year":"2021","journal-title":"Stem Cells Transl Med"},{"issue":"Suppl 1","key":"10.1016\/j.reth.2025.02.009_bib180","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.jcf.2019.11.002","article-title":"Intestinal organoids for cystic fibrosis research","volume":"19","author":"de Poel","year":"2020","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.reth.2025.02.009_bib181","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/MPG.0000000000001411","article-title":"Intestinal organoids: new frontiers in the study of intestinal disease and physiology","volume":"64","author":"Wallach","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"10.1016\/j.reth.2025.02.009_bib182","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-0044-1785234","article-title":"CRISPR-Cas9 gene editing: curing genetic diseases by inherited epigenetic modifications","volume":"11","author":"Kolanu","year":"2024","journal-title":"Glob Med Genet"},{"issue":"2","key":"10.1016\/j.reth.2025.02.009_bib183","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s40883-021-00219-w","article-title":"3D printing: advancement in biogenerative engineering to combat shortage of organs and bioapplicable materials","volume":"8","author":"Parihar","year":"2022","journal-title":"Regen Eng Transl Med"},{"issue":"8","key":"10.1016\/j.reth.2025.02.009_bib184","doi-asserted-by":"crossref","first-page":"782","DOI":"10.5152\/tjg.2023.23137","article-title":"The impact of cellular therapies on gastrointestinal diseases: applications and challenges","volume":"34","author":"Zhang","year":"2023","journal-title":"Turk J Gastroenterol"}],"container-title":["Regenerative Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352320425000355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352320425000355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T04:25:16Z","timestamp":1763699116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352320425000355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":184,"alternative-id":["S2352320425000355"],"URL":"https:\/\/doi.org\/10.1016\/j.reth.2025.02.009","relation":{},"ISSN":["2352-3204"],"issn-type":[{"type":"print","value":"2352-3204"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of cell-based therapies in digestive disorders: Obstacles and opportunities","name":"articletitle","label":"Article Title"},{"value":"Regenerative Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reth.2025.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier BV on behalf of The Japanese Society for Regenerative Medicine.","name":"copyright","label":"Copyright"}]}}